We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Clavis Pharma and Clovis Oncology Sign $380 Million Partnership

News   Nov 25, 2009

 
Clavis Pharma and Clovis Oncology Sign $380 Million Partnership
 
 
 

RELATED ARTICLES

More Effective Drug Combination Regimens to Treat TB Faster

News

UCLA researchers have identified a way to significantly reduce the duration of tuberculosis treatment using an approach called "artificial intelligence-parabolic response surface."

READ MORE

Huge Data Set Offers New Insights for Predicting Huntington Disease Age of Onset

News

Scientists have examined more than 25 years of data to reveal new insights into predicting the age of onset for Huntington disease.

READ MORE

Specialized Microscope Scans and Closes Single Blood Vessels

News

If further developed, this specialized microscope could be revolutionary for the treatment of skin cancer, as it enables incredibly precise surgery – all without cutting skin.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE